David Bouchey
Stock Analyst at Aegis Capital
(n/a)
# 5,114
Out of 5,240 analysts
8
Total ratings
n/a
Success rate
-51.53%
Average return
Main Sectors:
Stocks Rated by David Bouchey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SBFM Sunshine Biopharma | Reiterates: Buy | $7 | $0.66 | +960.45% | 3 | Oct 8, 2025 | |
| AEON AEON Biopharma | Reiterates: Buy | $7.2 | $0.82 | +778.05% | 1 | Oct 8, 2025 | |
| STSS Sharps Technology | Initiates: Buy | $105,600 | $1.96 | +5,387,655.10% | 1 | May 9, 2023 | |
| IINN Inspira Technologies Oxy B.H.N. | Maintains: Buy | $10 → $13 | $0.41 | +3,109.88% | 1 | Jan 25, 2023 | |
| RMTI Rockwell Medical | Downgrades: Outperform | $121 | $0.80 | +15,004.23% | 2 | Oct 19, 2018 |
Sunshine Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7
Current: $0.66
Upside: +960.45%
AEON Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7.2
Current: $0.82
Upside: +778.05%
Sharps Technology
May 9, 2023
Initiates: Buy
Price Target: $105,600
Current: $1.96
Upside: +5,387,655.10%
Inspira Technologies Oxy B.H.N.
Jan 25, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $0.41
Upside: +3,109.88%
Rockwell Medical
Oct 19, 2018
Downgrades: Outperform
Price Target: $121
Current: $0.80
Upside: +15,004.23%